FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

28691711000001105: Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Mar 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
90320101000001112 Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113114801000001112 Olsalazine 250mg capsules (Atnahs Pharma UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Is a Product containing precisely olsalazine sodium 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has active ingredient Olsalazine sodium false Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has specific active ingredient Olsalazine sodium true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) 112 capsule Has AMP True Olsalazine 250mg capsules (Marlborough Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start